Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05TYI
|
|||
| Drug Name |
Azaindole derivative 2
|
|||
| Synonyms |
PMID25656651-Compound-44
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ORIBASE PHARMA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H21F3N4O3
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)CNC3=CN=C4C(=C3)C=C(N4)C(=O)OC
|
|||
| InChI |
1S/C25H21F3N4O3/c1-14-6-7-19(31-23(33)15-4-3-5-18(8-15)25(26,27)28)10-17(14)12-29-20-9-16-11-21(24(34)35-2)32-22(16)30-13-20/h3-11,13,29H,12H2,1-2H3,(H,30,32)(H,31,33)
|
|||
| InChIKey |
QERVGYYPIGRNLQ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.